🟢 Adaptive Biotechnologies is trading 4.47% up in pre-market with no clear catalyst identified

Adaptive Biotechnologies is trading at $25.50, up 4.47% in pre-market; no clear company-specific announcement explaining the gain was found.

• The company’s next scheduled results are November 4, not an overnight earnings release.
• Reuters reported lower U.S. futures as investors weighed AI-spending concerns, but this does not explain the stock’s rise.
• Available information does not establish a direct catalyst or pre-market volume.